261 related articles for article (PubMed ID: 26786778)
1. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
Vandekerckhove L; Vermeulen Z; Liu ZZ; Boimvaser S; Patzak A; Segers VF; De Keulenaer GW
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E495-504. PubMed ID: 26786778
[TBL] [Abstract][Full Text] [Related]
2. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
Li B; Zheng Z; Wei Y; Wang M; Peng J; Kang T; Huang X; Xiao J; Li Y; Li Z
Cardiovasc Diabetol; 2011 Jul; 10():69. PubMed ID: 21798071
[TBL] [Abstract][Full Text] [Related]
4. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
5. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.
Yao Y; Fomison-Nurse IC; Harrison JC; Walker RJ; Davis G; Sammut IA
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F251-62. PubMed ID: 24899056
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.
Liu X; Gu X; Li Z; Li X; Li H; Chang J; Chen P; Jin J; Xi B; Chen D; Lai D; Graham RM; Zhou M
J Am Coll Cardiol; 2006 Oct; 48(7):1438-47. PubMed ID: 17010808
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1 attenuates stress-induced vascular senescence.
Shakeri H; Gevaert AB; Schrijvers DM; De Meyer GRY; De Keulenaer GW; Guns PDF; Lemmens K; Segers VF
Cardiovasc Res; 2018 Jun; 114(7):1041-1051. PubMed ID: 29528383
[TBL] [Abstract][Full Text] [Related]
9. Fcγ receptor deficiency attenuates diabetic nephropathy.
Lopez-Parra V; Mallavia B; Lopez-Franco O; Ortiz-Muñoz G; Oguiza A; Recio C; Blanco J; Nimmerjahn F; Egido J; Gomez-Guerrero C
J Am Soc Nephrol; 2012 Sep; 23(9):1518-27. PubMed ID: 22859852
[TBL] [Abstract][Full Text] [Related]
10. Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes.
Biederman JI; Vera E; Rankhaniya R; Hassett C; Giannico G; Yee J; Cortes P
Kidney Int; 2005 Feb; 67(2):554-65. PubMed ID: 15673303
[TBL] [Abstract][Full Text] [Related]
11. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
[TBL] [Abstract][Full Text] [Related]
15. Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.
Odiete O; Konik EA; Sawyer DB; Hill MF
Cardiovasc Diabetol; 2013 Mar; 12():52. PubMed ID: 23530877
[TBL] [Abstract][Full Text] [Related]
16. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
18. Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes.
Hammad SM; Hazen-Martin DJ; Sohn M; Eldridge L; Powell-Braxton L; Won W; Lyons TJ
Kidney Blood Press Res; 2003; 26(5-6):351-61. PubMed ID: 14610340
[TBL] [Abstract][Full Text] [Related]
19. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
[TBL] [Abstract][Full Text] [Related]
20. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
Lassila M; Jandeleit-Dahm K; Seah KK; Smith CM; Calkin AC; Allen TJ; Cooper ME
J Am Soc Nephrol; 2005 Feb; 16(2):363-73. PubMed ID: 15625075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
